These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21641984)

  • 1. In vitro and in vivo evaluation of an intraocular implant for glaucoma treatment.
    Natu MV; Gaspar MN; Fontes Ribeiro CA; Cabrita AM; de Sousa HC; Gil MH
    Int J Pharm; 2011 Aug; 415(1-2):73-82. PubMed ID: 21641984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A poly(ε-caprolactone) device for sustained release of an anti-glaucoma drug.
    Natu MV; Gaspar MN; Ribeiro CA; Correia IJ; Silva D; de Sousa HC; Gil MH
    Biomed Mater; 2011 Apr; 6(2):025003. PubMed ID: 21293056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in Rabbits.
    Fu J; Sun F; Liu W; Liu Y; Gedam M; Hu Q; Fridley C; Quigley HA; Hanes J; Pitha I
    Mol Pharm; 2016 Sep; 13(9):2987-95. PubMed ID: 27336794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of dorzolamide as added therapy in glaucoma patients with maximum tolerated drug therapy. A pilot study].
    Denk PO; Knorr M; Kriegerowski M; Thiel HJ
    Klin Monbl Augenheilkd; 1997 Jun; 210(6):360-4. PubMed ID: 9333661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of twice-daily and three-times-daily dosing of dorzolamide in ocular hypertension and primary open-angle glaucoma patients treated with latanoprost.
    Lupinacci AP; Netland PA; Fung KH; Evans D; Zhao Y
    Adv Ther; 2008 Mar; 25(3):231-9. PubMed ID: 18369537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension.
    Katz LJ; Simmons ST; Craven ER
    Curr Med Res Opin; 2007 Dec; 23(12):2971-83. PubMed ID: 17949534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The hypotensive action and side effects of the carboanhydrase inhibitor dorzolamide hydrochloride].
    Egorov AE
    Vestn Oftalmol; 1996; 112(2):3-4. PubMed ID: 9045485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
    Tamer C; Oksüz H
    Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K; Shirato S
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update in glaucoma: the new pharmacotherapies. Dorzolamide hydrochloride.
    Gould LF
    Can J Ophthalmol; 1998 Aug; 33(5):253-4; discussion 257-8. PubMed ID: 9740951
    [No Abstract]   [Full Text] [Related]  

  • 12. Poly-epsilon-caprolactone intravitreous devices: an in vivo study.
    Silva-Cunha A; Fialho SL; Naud MC; Behar-Cohen F
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2312-8. PubMed ID: 19117927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.
    Orzalesi N; Rossetti L; Invernizzi T; Bottoli A; Autelitano A
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2566-73. PubMed ID: 10937568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intraocular pressure in rabbits after administration of 10% L-arginine HCl in 2% Trusopt].
    Veselovský J; Oláh Z; Veselá A; Gressnerová S
    Cesk Slov Oftalmol; 2004 Apr; 60(2):81-8. PubMed ID: 15185445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model.
    Seki M; Tanaka T; Matsuda H; Togano T; Hashimoto K; Ueda J; Fukuchi T; Abe H
    Br J Ophthalmol; 2005 Apr; 89(4):504-7. PubMed ID: 15774933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.
    Janulevicienë I; Harris A; Kagemann L; Siesky B; McCranor L
    Acta Ophthalmol Scand; 2004 Dec; 82(6):730-7. PubMed ID: 15606472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits.
    Fouda NH; Abdelrehim RT; Hegazy DA; Habib BA
    Drug Deliv; 2018 Nov; 25(1):1340-1349. PubMed ID: 29869516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trusopt, a topical carbonic anhydrase inhibitor.
    Donohue EK; Wilensky JT
    J Glaucoma; 1996 Feb; 5(1):68-74. PubMed ID: 8795737
    [No Abstract]   [Full Text] [Related]  

  • 19. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
    Bournias TE; Lai J
    Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.
    Razeghinejad MR; Sawchyn AK; Katz LJ
    Expert Opin Pharmacother; 2010 Apr; 11(6):959-68. PubMed ID: 20307220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.